Print

Cerus Corporation (CERS) Announces First INTERCEPT Blood System Customer in Turkey  
8/7/2012 10:07:39 AM

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) announced today that Hemakim, Cerus’ distributor for Turkey, has signed an agreement with the Florence Nightingale Hospital, a leading medical center in Turkey, to supply the INTERCEPT Blood System for platelets and plasma.
//-->